Con 440 donantes que han permitido la realización de 931 trasplantes de órganos
Tal y como ha informado la ministra de sanidad, se ha llegado a los 48 donantes por millón de población (p.m.p.), con un total de 2.243 donantes, lo que ha permitido realizar 5.314 trasplantes de órganos, elevando la tasa de trasplantes a 114 p.m.p., la más alta del mundo.
The Exam for awarding the European Diploma in Transplant Medicine is organised by the European Board of Transplant Medicine of the Division of Transplantation of the UEMS in collaboration with the European Society of Organ Transplantation (ESOT).
Heart transplantation is the only cure for patients with terminal cardiac failure, but the supply of allogeneic donor organs falls far short of the clinical need1,2,3. Xenotransplantation of genetically modified pig hearts has been discussed as a potential alternative4. Genetically multi-modified pig hearts that lack galactose-α1,3-galactose epitopes (α1,3-galactosyltransferase knockout) and express a human membrane cofactor […]
Kidney disease carries a high burden for individual patients and for the medical system as a whole. End-stage kidney disease (ESKD) is associated with high mortality and decreased quality of life for many reasons including residual symptoms, pill burden, dietary restrictions, and decreased fertility. Kidney transplantation has benefits but is a limited resource, and the […]
Background Uterus transplantation from live donors became a reality to treat infertility following a successful Swedish 2014 series, inspiring uterus transplantation centres and programmes worldwide. However, no case of livebirth via deceased donor uterus has, to our knowledge, been successfully achieved, raising doubts about its feasibility and viability, including whether the womb remains viable after […]
Nabs and Autoantibodies Antibody-Mediated Rejection of Organ Transplants: Lessons From Animal Models
La Organización Nacional de Trasplantes (ONT) y la Sociedad Española de Nefrología (SEN) han firmado un convenio de colaboración
Abstract In a multicenter, open-label, study, 284 living-donor liver transplant patients were randomized at 30+/-5 days post-transplant to start everolimus+reduced tacrolimus (EVR+rTAC)
Abstract The phase III Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial-Extended Criteria Donors Trial